Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Need an Account?

Content is available to registered users only. Registration is free.

Register now, or if you’ve already registered, log in.
News

Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Posted: 10/25/2023
TCT News Articles 2023

Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB

Most Viewed Pages

Elevated Lp(a) Levels Linked to Interstitial, Replacement Myocardial Fibrosis by CMR Imaging, Study Finds

High Lp(a) Levels Linked to Increased PAD, AAAs, MALE Risk, Study Concludes

PVCs During Recovery, But Not During Exercise Testing, May Be Linked with CV Death Risk

Post-LAA Closure DRT Should Be Managed as Chronic Condition Until Regression, Concludes Study
Open

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Need an Account?

News

Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Most Viewed Pages

Explore the Site

Stay Connected